This trial is active, not recruiting.

Condition asthma
Sponsor New York University School of Medicine
Start date April 2002
End date January 2017
Trial size 2000 participants
Trial identifier NCT00212537, H9698


Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case control

Primary Outcomes

To recruit and characterize a cohort of subjects with asthma who reside in a high pollution, high asthma risk neighborhood
time frame: five yeARS

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Ages 18 and above Exclusion Criteria: - Greater than 10 pack year tobacco history - Lung diseases other than asthma

Additional Information

Official title Disease Modifying Genes in Severe Asthma
Principal investigator Joan Reibman, MD
Trial information was received from ClinicalTrials.gov and was last updated in March 2016.
Information provided to ClinicalTrials.gov by New York University School of Medicine.